Skip to content
SPCX$132.07-3.85(-2.83%)Stack Capital Group Inc. Reports Q3-2026 Financial Results7:45:00 AM ETCOP$138.49+1.55(+1.13%)BUZZ-ConocoPhillips rises on Q3 profit beat7:40:48 AM ETTGT$164.75+1.70(+1.04%)Target Looks More Attractive Than You'd Think7:31:07 AM ETCOP$138.49+1.55(+1.13%)UPDATE 2-ConocoPhillips beats estimates on higher oil prices, raises dividend7:30:23 AM ETCOP$138.49+1.55(+1.13%)ConocoPhillips Q3 profit beats on higher prices, hikes dividend7:26:13 AM ETMETA$637.14+7.14(+1.13%)UPDATE 2-Meta sells first bonds in euros, raises €9 billion7:25:25 AM ETDTE$137.45-0.06(-0.04%)UPDATE 1-DTE Energy to sell its non-utility business for about $3 billion7:23:30 AM ETAAPL$352.27+2.76(+0.79%)Jim Cramer's Surprise Midterm Winner: Apple, Because Fewer Data Centers Could Mean Cheaper Memory7:19:09 AM ETTSLA$376.70-8.49(-2.20%)Ferrari vs. Tesla: Can the Luce Outsell the Roadster?7:18:00 AM ETMU$756.01-39.45(-4.96%)Could Buying Micron Stock Today Help Set You Up for Life?7:17:00 AM ETMSFT$556.48+0.68(+0.12%)Microsoft Is Executing an Irreproducible Balance-Sheet-Backed Infrastructure Pre-Sale at Scale7:15:58 AM ETAAPL$352.27+2.76(+0.79%)Apple Vs. Tesla: Low CapEx Only Matters if Non-Cyclical Cash Flows Come With It7:15:57 AM ETIREN$20.90-0.80(-3.69%)IREN is Only Fit for a Specific Investor Currently7:15:22 AM ETCOP$138.49+1.55(+1.13%)BRIEF-Conocophillips Q3 Adjusted EPS USD 3.27 Vs. IBES Estimate USD 2.977:13:20 AM ETMU$756.01-39.45(-4.96%)Micron Just Closed Below $800 for the First Time Since July7:12:48 AM ETAAPL$352.27+2.76(+0.79%)Amazon, Apple, FTAI Aviation And A Basic Material Stock: CNBC's ‘Final Trades'7:12:08 AM ETCOP$138.49+1.55(+1.13%)ConocoPhillips beats profit estimates, boosts quarterly dividend7:11:13 AM ETCRWD$233.20-7.80(-3.24%)Too Late to Buy CrowdStrike Stock? Here's the 1 Thing to Watch.7:10:00 AM ETGOOG$289.36+2.06(+0.72%)These 6 Stocks Make Up a Big Share of the S&P 5007:09:00 AM ETCOP$138.49+1.55(+1.13%)UPDATE 1-ConocoPhillips beats profit estimates, boosts quarterly dividend7:07:07 AM ETLLY$1,433.10+14.96(+1.05%)Iconic California Brand, French Florist, Celebrates Grand Opening of First Indiana Location7:07:00 AM ETCVS$80.93+0.94(+1.18%)ProjectLeo, the First Private AI Health Platform to Declare Independence From Big Tech7:04:00 AM ETCOP$138.49+1.55(+1.13%)ConocoPhillips beats quarterly profit estimates7:01:40 AM ETCOP$138.49+1.55(+1.13%)ConocoPhillips announces third-quarter 2026 results and increases quarterly ordinary dividend by 11%7:00:05 AM ET

LNTH · NASDAQ

Lantheus Holdings, Inc.

$101.14 -0.01 (-0.01%)

Company overview

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent; Thallium-201 to detect cardiovascular disease; and Gallium-67 to detect various infections and cancerous tumors.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Market cap
$6.6B
Employees
808
Headquarters
Bedford, MA
CEO
Mary Anne Heino
Listed
June 25, 2015
P/E
24.02
Dividend yield
0.00%

Company financials

Revenue
$1.5B
Gross profit
$935M
Operating income
$290M
EBITDA
$370M
Net income
$279M
EPS
$4.21
Total assets
$2.3B
Total debt
$803,000
Gross margin
60.48%
Net margin
18.05%
Earnings yield
4.16%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

83.7091.0198.32105.63112.94
LNTH 1D NASDAQ O101.08H101.27L100.88C101.15+0.35 (+0.35%)Vol946.43K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
View
Ticker Type Headline Source Published
LNTHLantheus Holdings, Inc. Press release Lantheus Welcomes CMS CY27 Final Rule Advancing Access to Diagnostic Radiopharmaceuticals GlobeNewswire
LNTHLantheus Holdings, Inc. Press release Lantheus Reports Third Quarter 2026 Financial Results GlobeNewswire
LNTHLantheus Holdings, Inc. Stock news BRIEF-Lantheus Announces Presentation Of Data At The 2026 Clinical Trials On Alzheimer’S Disease Annual Meeting Reuters
LNTHLantheus Holdings, Inc. Stock news BRIEF-Lantheus Announces Presentation Of Data At The 2026 Clinical Trials On Alzheimer’S Disease Annual Meeting Reuters
LNTHLantheus Holdings, Inc. Press release Lantheus Announces Presentation of Data at the 2026 Clinical Trials on Alzheimer’s Disease Annual Meeting GlobeNewswire
LNTHLantheus Holdings, Inc. Stock news This Adobe Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday Benzinga
LNTHLantheus Holdings, Inc. Legal BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Option Care Health, Inc. (Nasdaq – OPCH), Lantheus Holdings Inc. (Nasdaq – LNTH), MarketAxess Holdings Inc. GlobeNewswire
LNTHLantheus Holdings, Inc. Stock news Lantheus Holdings, Inc. (NASDAQ:LNTH) Stock Rated “Hold” by Wall Street Analysts Defense World
LNTHLantheus Holdings, Inc. Legal Halper Sadeh LLC is Investigating Whether ITGR, FHB, INDV, GlobeNewswire
LNTHLantheus Holdings, Inc. Press release Lantheus Announces CMS Grants Transitional Pass-Through Status for PYLARIFY® TruVu (piflufolastat F 18) GlobeNewswire
LNTHLantheus Holdings, Inc. Legal BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: SoundThinking, Inc. (Nasdaq – SSTI), Lantheus Holdings Inc. (Nasdaq – LNTH), MarketAxess Holdings Inc. GlobeNewswire
LNTHLantheus Holdings, Inc. Legal ACT NOW - The M&A Class Action Firm Is Investigating the Merger -- FHB, INDV, ITGR, and LNTH PR Newswire
LNTHLantheus Holdings, Inc. Press release Lantheus Announces First Patient Dosed in SPARROW Phase 2/3 Registrational Trial in Prostate Cancer GlobeNewswire
LNTHLantheus Holdings, Inc. Legal Halper Sadeh LLC is Investigating Whether HOWL, BZH, MKTX, GlobeNewswire
LNTHLantheus Holdings, Inc. Legal BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), Lantheus Holdings Inc. (Nasdaq – LNTH), MarketAxess Holdings Inc. GlobeNewswire
LNTHLantheus Holdings, Inc. Press release Lantheus Receives Final FDA Approval for BRAVNETSA™ (Lutetium Lu 177 Dotatate), the Only Radiopharmaceutical FDA has Determined to be Bioequivalent and Therapeutically Equivalent to LUTATHERA® for the Treatment of GEP-NETs GlobeNewswire
LNTHLantheus Holdings, Inc. Stock news Are LNTH, ITGR, CZR Obtaining Fair Deals for their Shareholders? PRNewsWire
LNTHLantheus Holdings, Inc. Legal Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc. - LNTH Business Wire
LNTHLantheus Holdings, Inc. Legal LNTH Stock Alert: Halper Sadeh LLC is Investigating Whether Lantheus Holdings, Inc. is Obtaining a Fair Price for its Shareholders GuruFocus
LNTHLantheus Holdings, Inc. Legal LNTH Stock Alert: Halper Sadeh LLC is Investigating Whether Lantheus Holdings, Inc. is Obtaining a Fair Price for its Shareholders Business Wire
FAQ

Questions about Lantheus Holdings, Inc.

What does Lantheus Holdings, Inc. do?
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent; Thallium-201 to detect cardiovascular disease; and Gallium-67 to detect various infections and cancerous tumors.
What is LNTH's market cap?
Lantheus Holdings, Inc. (LNTH) is a listed stock with a live quote. The latest market cap on this page is $6.6B.
Where is Lantheus Holdings, Inc. headquartered?
Lantheus Holdings, Inc. is headquartered in Bedford, MA.
How do I get LNTH news from the API?
Call GET /v1/news?tickers=LNTH. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does LNTH news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for LNTH, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the LNTH price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.